Comparative evaluation of PRRS virus infection in vaccinated and naïve pigs

Research in Veterinary Science

Volumn 90, Issue 2, 2011, Pages 218-225

  Dotti, Silvia ^a   Villa, Riccardo ^a   Sossi, Enrico ^a   Guadagnini, Giovanni ^b   Salvini, Francesco ^b   Ferrari, Maura ^a   Amadori, Massimo ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL EMILIA ROMAGNA   (Italy)

^b Swine Practitioners   (Italy)

Author keywords

Antibody; Cytokines; PRRS; Vaccination

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIVE VACCINE; PORCINE CIRCOVIRUS TYPE 2 VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIBODY RESPONSE; ARTERIVIRUS INFECTION; ARTICLE; CELLULAR IMMUNITY; CIRCOVIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE FUNCTION; IMMUNE RESPONSE; IMMUNOASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; VACCINATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LEUKOCYTES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; SWINE; VIRAL VACCINES; VIREMIA;

ANIMALIA; PORCINE CIRCOVIRUS 2; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE;

EID: 79951774555     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.06.011     Document Type: Article

References (32)

1. Ansari I.H., Kwon B., Osorio F.A., Pattnaik A.K. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J. Virol. 2006, 80:3994-4004.
2. Asai T., Okada M., Ono M., Irisawa T., Mori Y., Yokomizo Y., Sato S. Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae. Vet. Immunol. Immunopathol. 1993, 38:253-260.
3. Chung W.B., Chan W.H., Chaung H.C., Lien Y., Wu C.C., Huang Y.L. Real-time PCR for quantitation of porcine reproductive and respiratory syndrome virus and porcine circovirus type 2 in naturally-infected and challenged pigs. J. Virol. Meth. 2005, 124:11-19.
4. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2005, 86, Pt 7:1943-1951.
5. Diaz I., Mateu E. Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigs. Vet. Immunol. Immunopathol. 2005, 106:107-112.
6. Ferrari M., Candotti P., Lombardi G., Amadori M., Dotti S., Guana S., Petrini S. A comparison of the humoral and cell-mediated response of pigs experimentally infected with either influenza or PRRS viruses. Vet. Res. Commun. 2008, 32(Suppl. 1):S199-S201.
7. Kiss I., Sami L., Kecskemeti S., Hanada K. Genetic variation of the prevailing porcine respiratory and reproductive syndrome viruses occurring on a pig farm upon vaccination. Arch. Virol. 2006, 151:2269-2276.
8. Kritas S.K., Morrison R.B. Effect of orally administered Lactobacillus casei on porcine reproductive and respiratory syndrome (PRRS) virus vaccination in pigs. Vet. Microbiol. 2007, 119:248-255.
9. Labarque G., Reeth K.V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 2004, 22:4183-4190.
10. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., Bottarelli E., Borghetti P. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 2009, 27:3788-3799.
11. Mateu E., Diaz I. The challenge of PRRS immunology. Vet. J. 2008, 177:345-351.
12. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet. Microbiol. 2000, 74:309-329.
13. Murtaugh M.P., Xiao Z., Zuckermann F. Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol. 2002, 15:533-547.
14. Okuda Y., Kuroda M., Ono M., Chikata S., Shibata I. Efficacy of vaccination with porcine reproductive and respiratory syndrome virus following challenges with field isolates in Japan. J. Vet. Med. Sci. 2008, 70:1017-1025.
15. Papatsiros V.G., Alexopoulos C., Kritas S.K., Koptopoulos G., Nauwynck H.J., Pensaert M.B., Kyriakis S.C. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows. J. Vet. Med. B Infect. Dis. Vet. Public Health 2006, 53:266-272.
16. Piras F., Bollard S., Laval F., Joisel F., Reynaud G., Charreyre C., Andreoni C., Juillard V. Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine. Viral Immunol. 2005, 18:381-389.
17. Plana-Duran J., Bastons M., Urniza A., Vayreda M., Vila X., Mane H. Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 1997, 55:361-370.
18. Prieto C., Alvarez E., Martinez-Lobo F.J., Simarro I., Castro J.M. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred. Vet. J. 2008, 175:356-363.
19. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27:493.
20. Revilla-Fernandez S., Wallner B., Truschner K., Benczak A., Brem G., Schmoll F., Mueller M., Steinborn R. The use of endogenous and exogenous reference RNAs for qualitative and quantitative detection of PRRSV in porcine semen. J. Virol. Meth. 2005, 126:21-30.
21. Sala, G., Rigola, S., Alborali, G.L., Brocchi, E., Cordioli, P., 2000. Development of monoclonal antibodies-based ELISAs for the detection of antibodies against porcine circovirus type 1 and type 2. In: Proceedings of the 5th International Congress of Veterinary Virology, Brescia, Italy, 27-30 August, pp. 253-254.
22. Scortti M., Prieto C., Alvarez E., Simarro I., Castro J.M. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV. Vet. Rec. 2007, 161:809-813.
23. Stadejek T., Oleksiewicz M.B., Potapchuk D., Podgorska K. Porcine reproductive and respiratory syndrome virus strains of exceptional diversity in eastern Europe support the definition of new genetic subtypes. J. Gen. Virol. 2006, 87:1835-1841.
24. Thanawongnuwech R., Brown G.B., Halbur P.G., Roth J.A., Royer R.L., Thacker B.J. Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection. Vet. Pathol. 2000, 37:143-152.
25. Van Gucht S., van Reeth K., Pensaert M. Interaction between porcine reproductive-respiratory syndrome virus and bacterial endotoxin in the lungs of pigs: potentiation of cytokine production and respiratory disease. J. Clin. Microbiol. 2003, 41:960-966.
26. Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., Kragten C., van Buiten L., den Besten A., Wagenaar F. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet. Q. 1991, 13:121-130.
27. Wills R.W., Gray J.T., Fedorka-Cray P.J., Yoon K.J., Ladely S., Zimmerman J.J. Synergism between porcine reproductive and respiratory syndrome virus (PRRSV) and Salmonella choleraesuis in swine. Vet. Microbiol. 2000, 71:177-192.
28. Yoon I.J., Joo H.S., Goyal S.M., Molitor T.W. A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. J. Vet. Diagn. Invest. 1994, 6:289-292.
29. Yoon K.J., Wu L.L., Zimmerman J.J., Platt K.B. Field isolates of porcine reproductive and respiratory syndrome virus (PRRSV) vary in their susceptibility to antibody dependent enhancement (ADE) of infection. Vet. Microbiol. 1997, 55:277-287.
30. Zhiping W., Malmberg P., Larsson B.M., Larsson K., Larsson L., Saraf A. Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am. J. Respir. Crit. Care Med. 1996, 154:1261-1266.
31. Zimmerman J., Benfield D.A., Murtaugh M.P., Osorio F., Stevenson G.W., Tottemorell M. Porcine reproductive and respiratory syndrome virus (Porcine Arterivirus). Diseases of Swine 2006, 387-417. Blackwell Publishing Professional, Ames. 9th edition. B.E. Straw, J.J. Zimmerman, S. D'Allaire, D.J. Taylor (Eds.).
32. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., Osorio F. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet. Microbiol. 2007, 123:69-85.